SERINC1
Serine incorporator 1
Also known as: KIAA1253, SERC1_HUMAN, TDE1L, TDE2, TMS-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRX5
- Gene
- SERINC1
- Ensembl
- ENSG00000111897
- Chromosome
- 6
- Canonical length
- 453 aa
- Protein class
- Plasma proteins, Predicted membrane proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Predicted to enable acetyltransferase activator activity; enzyme binding activity; and protein-macromolecule adaptor activity. Predicted to be involved in membrane biogenesis; phosphatidylserine metabolic process; and sphingolipid metabolic process. Predicted to be located in endoplasmic reticulum membrane and plasma membrane. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
453 residues, UniProt reviewed canonical sequence.
>Q9NRX5|SERINC1
1 MGSVLGLCSM ASWIPCLCGS APCLLCRCCP SGNNSTVTRL IYALFLLVGV CVACVMLIPG
61 MEEQLNKIPG FCENEKGVVP CNILVGYKAV YRLCFGLAMF YLLLSLLMIK VKSSSDPRAA
121 VHNGFWFFKF AAAIAIIIGA FFIPEGTFTT VWFYVGMAGA FCFILIQLVL LIDFAHSWNE
181 SWVEKMEEGN SRCWYAALLS ATALNYLLSL VAIVLFFVYY THPASCSENK AFISVNMLLC
241 VGASVMSILP KIQESQPRSG LLQSSVITVY TMYLTWSAMT NEPETNCNPS LLSIIGYNTT
301 STVPKEGQSV QWWHAQGIIG LILFLLCVFY SSIRTSNNSQ VNKLTLTSDE STLIEDGGAR
361 SDGSLEDGDD VHRAVDNERD GVTYSYSFFH FMLFLASLYI MMTLTNWYRY EPSREMKSQW
421 TAVWVKISSS WIGIVLYVWT LVAPLVLTNR DFDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SERINC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 451 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 451 nTPM
- cerebral cortex: 348 nTPM
- midbrain: 318 nTPM
- hypothalamus: 253 nTPM
- hippocampal formation: 240 nTPM
- amygdala: 235 nTPM
Single-cell type
- neutrophils: 603 nCPM
- kupffer cells: 297 nCPM
- monocytes: 204 nCPM
- corticotrophs: 194 nCPM
- lymphatic endothelial cells: 190 nCPM
- retinal pigment epithelial cells: 179 nCPM
Immune cell
- basophil: 159 nTPM
- neutrophil: 109 nTPM
- eosinophil: 93 nTPM
- non-classical monocyte: 62 nTPM
- total PBMC: 56 nTPM
- T-reg: 54 nTPM
Brain region
- white matter: 484 nTPM
- pons: 437 nTPM
- spinal cord: 414 nTPM
- hypothalamus: 389 nTPM
- medulla oblongata: 373 nTPM
- midbrain: 364 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.36
- DepMap mean gene effect
- 0.21
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- membrane biogenesis
- phosphatidylserine metabolic process
- phospholipid biosynthetic process
- sphingolipid metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SERINC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SERINC1 as an antibody target. Whether an autoantibody or antibody against SERINC1 could matter depends on whether native SERINC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SERINC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SERINC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...